EcoDrugPlus

Atpase Na+/k+ Transporting Subunit Alpha 2a

Ensembl ID : ENSCSEG00000021656
Gene Symbol: ATP1A2A
1 Cross references
205 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSCSEG00000003338
Gene Symbol: ATP1B1
3 Cross references
216 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSCSEG00000006274
Gene Symbol: ATP1B2
3 Cross references
190 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3

Ensembl ID : ENSCSEG00000017427
Gene Symbol: ATP1B3
3 Cross references
229 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSCSEG00000003676
Gene Symbol: ATR
3 Cross references
205 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSCSEG00000005564
Gene Symbol: AXL
4 Cross references
188 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSCSEG00000016152
Gene Symbol: BRAF
1 Cross references
220 Possible Orthologues:

B2 Bradykinin Receptor

Ensembl ID : ENSCSEG00000004755
Gene Symbol: LOC103379665
3 Cross references
149 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSCSEG00000018082
Gene Symbol: BCL2
3 Cross references
172 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSCSEG00000002958
Gene Symbol: BCL2L1
4 Cross references
229 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSCSEG00000009904
Gene Symbol: BCL2L1
1 Cross references
216 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSCSEG00000003567
Gene Symbol: BCR
3 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).